Get our Newsletter
Sign up to receive the Pet Perspective, a monthly e-newsletter filled with videos and articles about pet health and other fun topics.
Participation in any clinical trial being conducted at a BluePearl Veterinary Partners hospital requires a referral from your family veterinarian. If you and your veterinarian are interested in learning more about enrollment in one of our active trials, please have your family veterinarian contact the doctor conducting the study.
**We are sorry, but we cannot take calls directly from pet owners about our clinical trials.
Study being conducted at all five BluePearl Veterinary Partners hospitals in Washington: Seattle, Renton, Tacoma and Seattle Veterinary Specialists in Kirkland and Seattle. Click here to see the full description and contact information for each participating hospital.
(As of June 2016, enrollment suspended indefinitely)
Study being conducted in Florida and Michigan. Click here to see the full description and contact information for each participating hospital.
Study being conducted in Minnesota at our Eden Prairie hospital. Click here to see the full description and contact information for this study.
Study being conducted in Florida. Click here to see the full description and contact information for this study.
When a treatment that the FDA newly or conditionally approves becomes available, it is often expensive and may be difficult to obtain. Additionally, the company that develops the new product or medication often seeks more information on the scope of its use. Because of this, some companies provide the new product or medication at a discounted rate to BluePearl. Our specialists then provide further input to the company on the medication’s use in practice.
This type of arrangement is known as a “clinical experience” or “practice experience.” When BluePearl participates in one of these protocols, the specialist will discuss this option with the primary care veterinarian and the patient’s family. Cost savings are passed along to the pet owner.
Novel Therapeutic for the Treatment of T- and B-cell Lymphoma in Dogs:
BluePearl Veterinary Partners in Florida, Kentucky, Michigan, and New York participated in a program to provide a new monoclonal antibody (MAb) therapy available for the treatment of lymphoma in dogs. Developed specifically for dogs with lymphoma, canine MAb therapy is an innovative treatment that’s designed to target and kill lymphoma cells.